PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsYoichi Nagata, Dihua Yu, Xiaoyan Zhou et al.|Cancer Cell|2004Cited by 1.9k
ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer CellsKristine S. Klos, Dihua Yu|Cancer Research|2006Cited by 200
Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment aloneKristine S. Klos, Dihua Yu|Cancer|2003Cited by 110
Genotoxic Exposure during Juvenile Growth of Mammary Gland Depletes Stem Cell Activity and Inhibits Wnt SignalingKristine S. Klos, Caroline M. Alexander|PLoS ONE|2012Cited by 3